CeeTox™ Analysis of CNB-001 a Novel Curcumin-Based Neurotrophic/Neuroprotective Lead Compound to Treat Stroke: Comparison with NXY-059 and Radicut.
about
Resolving the negative data publication dilemma in translational stroke research.A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy?Effect of the Pleiotropic Drug CNB-001 on Tissue Plasminogen Activator (tPA) Protease Activity in vitro: Support for Combination Therapy to Treat Acute Ischemic Stroke.J-147 a Novel Hydrazide Lead Compound to Treat Neurodegeneration: CeeTox(™) Safety and Genotoxicity Analysis.Emerging Therapies: Pleiotropic Multi-target Drugs to Treat Stroke VictimsCurcumin accelerates reendothelialization and ameliorates intimal hyperplasia in balloon-injured rat carotid artery via the upregulation of endothelial cell autophagy.Drug-like property profiling of novel neuroprotective compounds to treat acute ischemic stroke: guidelines to develop pleiotropic moleculesFast neuroprotection (fast-NPRX) for acute ischemic stroke victims: the time for treatment is now.Novel curcumin derivative CNB-001 mitigates obesity-associated insulin resistance.Hybrid curcumin compounds: a new strategy for cancer treatment.De-Risking of Stilbazulenyl Nitrone (STAZN), a Lipophilic Nitrone to Treat Stroke Using a Unique Panel of In Vitro Assays.Investigating the therapeutic role and molecular biology of curcumin as a treatment for glioblastomaNonclinical toxicological evaluation of occidiofungin, a unique glycolipopeptide antifungal.Fluorination Effects on NOS Inhibitory Activity of Pyrazoles Related to Curcumin."Clicked" sugar-curcumin conjugate: modulator of amyloid-β and tau peptide aggregation at ultralow concentrations.4-((1E)-2-(5-(4-hydroxy-3-methoxystyryl-)-1-phenyl-1H-pyrazoyl-3-yl) vinyl)-2-methoxy-phenol) (CNB-001) Does Not Regulate Human Recombinant Protein-Tyrosine Phosphatase1B (PTP1B) Activity in vitro.
P2860
Q33930564-9849C138-D8DA-4A1C-9672-A58BBBCA091FQ33938450-95E04904-A09E-47D9-85D6-2AD0BAD191CAQ34432486-F43C8C69-A60F-460A-AD07-1F809E915BBCQ34433111-B6FB4575-B2BE-46EB-BAB6-2D3A4BDB9833Q35029799-489CB899-E241-4743-AA24-2E141A6FEFD9Q36369243-C9FFAB77-E22C-4852-9A2E-C382E391D4FEQ36841904-6431EB80-C73C-44A3-A2E5-898EB9566D17Q37420266-E91DD851-883B-479C-BF7E-EF2A1819EFDDQ37707726-D93DC191-CEDE-4A26-BF8F-1F6DF290EA70Q38290418-607691BD-E5D6-4A9C-A092-D49B9B1D79D9Q38681976-BAE33AB3-8CCC-4FDC-9427-3298D01650E5Q38915880-176F52E6-0D48-4B4B-8A01-89251E152E0EQ39332767-9233022E-C5E5-4389-BEE8-5336C299EBACQ40569105-2A9195CF-E2DC-4328-AEDD-1B4E68FAB983Q41992508-A54FFAFC-D0A2-451B-974D-E866F26B633BQ42030786-38A02FEF-F4FC-4697-AB1A-295BED864244
P2860
CeeTox™ Analysis of CNB-001 a Novel Curcumin-Based Neurotrophic/Neuroprotective Lead Compound to Treat Stroke: Comparison with NXY-059 and Radicut.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
CeeTox™ Analysis of CNB-001 a ...... ison with NXY-059 and Radicut.
@en
CeeTox™ Analysis of CNB-001 a ...... ison with NXY-059 and Radicut.
@nl
type
label
CeeTox™ Analysis of CNB-001 a ...... ison with NXY-059 and Radicut.
@en
CeeTox™ Analysis of CNB-001 a ...... ison with NXY-059 and Radicut.
@nl
prefLabel
CeeTox™ Analysis of CNB-001 a ...... ison with NXY-059 and Radicut.
@en
CeeTox™ Analysis of CNB-001 a ...... ison with NXY-059 and Radicut.
@nl
P2860
P1476
CeeTox™ Analysis of CNB-001 a ...... ison with NXY-059 and Radicut.
@en
P2093
James M McKim
P2860
P2888
P356
10.1007/S12975-010-0034-4
P577
2011-03-01T00:00:00Z